Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)

The summary for the Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
	CFDA Number:	93.172
	CFDA Description:	Human Genome Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-HG-06-004
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Dec 15, 2005
	Creation Date:	Dec 15, 2005
	Original Closing Date for Applications:	Feb 17, 2006
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Mar 19, 2006
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$1,500,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Only United States small business concerns (SBCs) are eligible to submit SBIR applications. A small business concern is one that, at the time of the award for both Phase I and Phase II SBIR awards, meets all of the following criteria: 1. Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. 2. Is (a) at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, or (b) for SBIR only, it must be a for-profit business concern that is at least 51% owned and controlled by another for-profit business concern that is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. 3. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term "affiliates" is defined in greater detail in 13 C.F.R. 121.103. The term "number of employees" is defined in 13 C.F.R. 121.106. A business concern may be in the form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust, or cooperative. Further information may be obtained at http://sba.gov/size, or by contacting the Small Business Administration's Government Contracting Area Office or Office of Size Standards.
Grant Description: This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) to develop novel technologies that will enable extremely low-cost genomic DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $10 to $50 million; the goal of this initiative is to reduce costs by at least four orders of magnitude, so that a mammalian-sized genome could be sequenced for approximately $1000. Substantial fundamental research is needed to develop the scientific and technological knowledge underpinning such a major advance. Therefore, it is anticipated that the long-term goals of this Request for Applications (RFA) funding opportunity may be achieved in ten years.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-06-004.html http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-06-004.html
Grant Announcement Contact: Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email FBOWebmaster@mail.nih.gov FBOWebmaster@mail.nih.gov Webmaster, NIH
Similar Government Grants: • NIH Small Research Grant Program (Parent R03); • NIH Exploratory/Developmental Research Grant Program (Parent R21); • Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Researc...; • The Electronic Medical Records and Genomics (eMERGE) Network, Phase II Pediatric Study Investigators...; • Technology Development for High-Throughput Functional Genomics (R21); • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44); • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - STTR (R41/R42); • A Data Coordination Center for the Knockout Mouse Project (KOMP); • LARGE SCALE SEQUENCING CAPACITY